As global trade policies shift and compliance pressures mount, pharma [...]

The US Pharmacopeia (USP) has recognized mass photometry as a [...]

Appointments enhance clinical expertise as GPR17 modulator progresses toward trials [...]

START unveils the Hope Hub, a digital platform connecting patients, [...]

Thermo Fisher Scientific has introduced a new version of its [...]

Data presented at ISTH 2025 highlight potential for improved outcomes [...]

New alliance targets early 2026 for first-in-human trial of non-opioid [...]

First-of-its-kind software aims to improve treatment decisions for patients with [...]

Ascidian Therapeutics has appointed Murray Abramson as chief development officer. [...]

Galapagos has announced promising results from Cohort 3 of its [...]